Maybe after the Doctors Peer review.
BIT to treat the HIV in macrophages. No other competition. Part of the Cure.
The question is which Big Pharma will combine with BIT?
Gilead is in poll position as they combined successfully with Atripla already in Phase ii.
or
They can do non-exclusive deals with all BIG Pharma!
$5 Billion looks pretty lowball.
- Forums
- ASX - By Stock
- HIV Cure --new breakthrough
Maybe after the Doctors Peer review.BIT to treat the HIV in...
Featured News
Add BIT (ASX) to my watchlist
|
|||||
Last
3.8¢ |
Change
0.001(2.70%) |
Mkt cap ! $34.28M |
Open | High | Low | Value | Volume |
3.7¢ | 4.0¢ | 3.7¢ | $68.85K | 1.794M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 150000 | 3.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.0¢ | 349950 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 150000 | 0.037 |
5 | 415000 | 0.036 |
5 | 724214 | 0.035 |
2 | 106000 | 0.033 |
3 | 91250 | 0.032 |
Price($) | Vol. | No. |
---|---|---|
0.040 | 299950 | 2 |
0.041 | 144000 | 2 |
0.042 | 117600 | 1 |
0.043 | 102000 | 1 |
0.045 | 120000 | 1 |
Last trade - 15.10pm 28/06/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online